ResMed reported $533.74M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Ansell USD 185.8M 7M Dec/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 26.8M 480K Sep/2026
Baxter International USD 474M 165M Jun/2026
Cochlear AUD 306.4M 13.5M Dec/2025
Cooper Companies USD 67.9M 255.5M Mar/2026
CSL USD 3.13B 1.17B Dec/2025
Dexcom USD 435.2M 46.5M Sep/2026
Edwards Lifesciences USD 562.2M 6.6M Jun/2026
Fisher Paykel Healthcare NZD 434M 70M Jun/2026
Globus Medical USD 262.21M 17.63M Sep/2026
Haemonetics USD 111.41M 15.25M Sep/2026
Idexx Laboratories USD 447.35M 21.11M Sep/2026
Insulet USD 233.7M 33.9M Sep/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Philips EUR 772M 138M Sep/2026
Ramsay Health Care AUD 1.12B 10.6M Dec/2025
ResMed USD 533.74M 26.04M Sep/2026
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Steris USD 413.1M 29.9M Jun/2026
Teleflex USD 122.91M 47.28M Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026